Find and Pitch Jounalists, Get Your Story Covered

Tags: biotechnology jobs Pharmaceuticals STAT+health tech

	Profile	Recent Articles on Subject
1	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: The end of 23andMe’s drug discovery dream - 3 days ago STAT+: How a tweet about a gene discovered long ago led to a $190 million startup and, maybe, hope for heart disease - 5 months ago STAT+: Why Sanofi got shellacked - about 1 year ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Up and down the ladder: The latest comings and goings - 6 days ago STAT+: AstraZeneca says China has detained a senior executive - 8 days ago STAT+: Up and down the ladder: The latest comings and goings - 13 days ago STAT+: Two generic drugmakers to pay $49 million to settle price-fixing charges - 14 days ago STAT+: Up and down the ladder: The latest comings and goings - 20 days ago STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more - 24 days ago STAT+: Up and down the ladder: The latest comings and goings - 27 days ago STAT+: Consumer and labor groups urge FTC to block Catalent sale to Novo Holdings - 28 days ago STAT+: Up and down the ladder: The latest comings and goings - about 1 month ago STAT+: Up and down the ladder: The latest comings and goings - 2 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: Up and down the ladder: The latest comings and goings - 3 months ago STAT+: A Senate bill was touted as a cure for ‘patent thickets.’ Some say the drug industry watered it down - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 4 months ago STAT+: Up and down the ladder: The latest comings and goings - 5 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 7 months ago STAT+: Up and down the ladder: The latest comings and goings - 8 months ago STAT+: Up and down the ladder: The latest comings and goings - 12 months ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago STAT+: Up and down the ladder: The latest comings and goings - about 1 year ago
3	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Novo Nordisk reports continued growth in obesity drug sales - 8 days ago STAT+: Merck drug for rare cardiovascular condition approved in U.S. - 8 months ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: Novo Nordisk reports continued growth in obesity drug sales - 8 days ago STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study - 2 months ago STAT+: Incyte’s checkpoint inhibitor staves off disease progression in anal cancer trial - 2 months ago STAT+: A new drug offers a rare option for brain cancer treatment — and inspires hopes for more - 2 months ago STAT+: Europe is set to shake up the way it assesses new medicines. Gene therapy makers are worried - 5 months ago STAT+: A scientific mystery highlights the blind spots in genomics databases - 8 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - about 1 year ago STAT+: A Q&A with the global head of Boehringer Ingelheim’s innovation unit - about 1 year ago
5	Tara Bannow STAT News Reporter @statnews. healthcarejournalism	STAT+: The dropped call that took down Centene’s Medicare Advantage star ratings - 17 days ago STAT+: For the behemoth UnitedHealth, a new threat to Medicare profits - 20 days ago STAT+: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds - 21 days ago STAT+: Medicare Advantage market expected to grow in 2025, despite big changes from insurers - about 1 month ago STAT+: Humana cutting Medicare Advantage plans that cover 10% of members - 2 months ago STAT+: UnitedHealthcare’s latest contract dispute, this time with Trinity Health, leaves thousands out-of-network - 3 months ago
6	Casey Ross STAT News National health tech writer @statnews. Covers #AI, #digitalhealth. Cleveland, OH health technologyjournalismartificial intelligencedigital health	STAT+: For the behemoth UnitedHealth, a new threat to Medicare profits - 20 days ago STAT+: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds - 21 days ago STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows - 28 days ago STAT+: AI in medicine: A national registry could help increase transparency, experts say - 3 months ago STAT Virtual Event: Putting AI to the Test - about 1 year ago
7	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds - 21 days ago STAT+: 3 medtech trends to watch in 2024 - 11 months ago STAT+: How the CEO of the largest medical device accelerator molds medtech startups - 12 months ago
8	Bob Herman STAT News Health care business reporter. Indiana Health carebusiness	STAT+: UnitedHealth collected billions in questionable Medicare payments, federal watchdog finds - 21 days ago STAT+: Former UnitedHealth doctors detail what changed at their clinics after takeovers - 28 days ago STAT+: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows - 28 days ago STAT+: Medicare Advantage market expected to grow in 2025, despite big changes from insurers - about 1 month ago STAT+: UnitedHealth sues Medicare to reverse downgraded star ratings - about 1 month ago STAT+: Private equity firms to acquire health care billing and payments firm R1 in $8.9 billion deal - 3 months ago STAT+: Why health care spending keeps climbing - 5 months ago
9	Mohana Ravindranath STAT News Health tech reporter at STAT. Oakland, CA + Washington, D.C. Health techreporting	STAT+: General Catalyst raises $8 billion, with $750 million for health care bets - 21 days ago STAT+: Washington wants to avert another Change Healthcare-like fiasco. Here’s what could be coming - 8 months ago STAT+: FTC’s Lina Khan makes a stop at Y Combinator, how telehealth helps rural America - about 1 year ago STAT+: How doctors and nurses shape Google’s AI, DEA extends telehealth flexibilities - about 1 year ago
10	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Study on Sarepta Therapeutics’ Duchenne therapy diverges from the company line - 21 days ago STAT+: Gilead needs a win with Arcellx CAR-T data. Here’s how to know if it scores - 21 days ago STAT+: Alnylam versus BridgeBio: The ATTR-CM debate - 2 months ago STAT+: Summit Therapeutics vs. Merck: Prepping for a big lung cancer study reveal - 2 months ago STAT+: On Andrew Left and the government’s fraud case - 4 months ago STAT+: The inside story of Enhertu’s pan-tumor approval - 7 months ago STAT+: Weed for weight loss, and more from Biotech Land - 7 months ago STAT+: A contrarian view on Viking Therapeutics, biotech’s hottest obesity stock - 8 months ago STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch - 11 months ago STAT Virtual Event \| Cancer’s Breakthrough Engine - 11 months ago

Journalists covering STAT+